Literature DB >> 19635888

Persistent eosinophilia and Strongyloides infection in Montagnard refugees after presumptive albendazole therapy.

Neela D Goswami1, J Jina Shah, G Ralph Corey, Jason E Stout.   

Abstract

Chronic helminth infections are common in refugee populations and may persist years after immigration. Asymptomatic Strongyloides stercoralis infection raises particular concern because of its potential for complications in immunosuppressed patients. We examined 172 Montagnard refugees resettled to Wake County, North Carolina from 2002 through 2003. Refugees were pretreated with albendazole for five days and screened for health conditions after arrival. Eosinophilia was present in 41 of 171 refugees at the first blood draw. Only 1 of 172 had a stool helminth (Fasciola) identified by microscopy. On repeat testing, 13 people had persistent eosinophilia. Results of serologic analysis for Strongyloides were available in 24 persons. Eosinophil counts decreased significantly after treatment with ivermectin in nine refugees (P = 0.039). Persistent eosinophilia, likely caused by Strongyloides infection, was common in this cohort of Montagnard refugees. Clinicians should understand the limitations of stool microscopy in diagnosis of strongyloidiasis, the limited effectiveness of albendazole in treating strongyloidiasis, and the importance of following-up refugees with persistent eosinophilia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635888

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  2 in total

1.  57-Year-old man with fever, rash, chronic watery diarrhea, cough, and sweats.

Authors:  Elfriede A Agyemang; Abinash Virk
Journal:  Mayo Clin Proc       Date:  2012-11       Impact factor: 7.616

Review 2.  Strongyloidiasis--an insight into its global prevalence and management.

Authors:  Santhosh Puthiyakunnon; Swapna Boddu; Yiji Li; Xiaohong Zhou; Chunmei Wang; Juan Li; Xiaoguang Chen
Journal:  PLoS Negl Trop Dis       Date:  2014-08-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.